 <h1>Savella Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>milnacipran</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about milnacipran. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Savella.</p><h2>In Summary</h2><p><b>Common side effects of Savella include:</b> hypertensive crisis, constipation, dizziness, headache, hot flash, nausea, and insomnia. <b>Other side effects include:</b> hypertension, increased heart rate, migraine, palpitations, skin rash, vomiting, anxiety, increased pulse, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, hyperhidrosis, and xerostomia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to milnacipran: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Milnacipran hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to drugs used to treat depression and other psychiatric disorders. Antidepressants increased the risk compared with placebo of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies with major depressive disorder (MDD) and other psychiatric disorders. Short term studies did not show an increase in the risk of suicidality with antidepressants compared with placebo in adults beyond age 24 years, and there was a reduction in risk with antidepressants compared with placebo in adults aged 65 or older. This risk must be balanced with clinical need. Monitor patients closely for clinical worsening, suicidality, or unusual changes in behavior. Advise families and caregivers of the need for close observation and communication with the prescriber. Milnacipran hydrochloride is not approved for treatment of MDD or for use in pediatric patients.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, milnacipran (the active ingredient contained in Savella) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking milnacipran:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>difficulty with breathing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>fear or nervousness</li>
<li>fever</li>
<li>headache</li>
<li>increased sweating</li>
<li>loss of voice</li>
<li>nasal congestion</li>
<li>pounding in the ears</li>
<li>runny nose</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>decrease in frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficult or painful urination</li>
<li>difficulty in passing urine (dribbling)</li>
<li>frequent urination</li>
<li>groin pain</li>
<li>muscle aches</li>
<li>pain or burning with urination</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>swollen, tender prostate</li>
<li>tightness in the chest</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bladder pain</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bloody or cloudy urine</li>
<li>bruise</li>
<li>discouragement</li>
<li>fall</li>
<li>feeling sad or empty</li>
<li>frequent urge to urinate</li>
<li>full or bloated feeling</li>
<li>heartburn</li>
<li>increased or decreased weight</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of interest or pleasure</li>
<li>lower back or side pain</li>
<li>pressure in the stomach</li>
<li>rapid weight gain</li>
<li>swelling of the abdominal or stomach area</li>
<li>tingling of the hands or feet</li>
<li>tiredness</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>blood in the urine or stools</li>
<li>coma</li>
<li>confusion as to time, place, or person</li>
<li>convulsions</li>
<li>dark-colored urine</li>
<li>decreased urine output</li>
<li>diarrhea</li>
<li>difficulty with swallowing</li>
<li>general tiredness and weakness</li>
<li>high fever</li>
<li>holding false beliefs that cannot be changed by fact</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>itching</li>
<li>joint or muscle pain</li>
<li>light-colored stools</li>
<li>loss of balance control</li>
<li>loss of consciousness</li>
<li>mask-like face</li>
<li>muscle cramps or spasms</li>
<li>muscle pain or stiffness</li>
<li>overactive reflexes</li>
<li>pinpoint red spots on the skin</li>
<li>poor coordination</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>restlessness</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>seizures</li>
<li>severe muscle stiffness</li>
<li>shuffling walk</li>
<li>slowed movements</li>
<li>slurred speech</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stiffness of the arms and legs</li>
<li>sweating</li>
<li>swelling of the face, ankles, fingers, or lower legs</li>
<li>swollen glands</li>
<li>talking or acting with excitement you cannot control</li>
<li>tic-like (jerky) movements of the head, face, mouth, and neck</li>
<li>tiredness</li>
<li>trembling and shaking of the fingers and hands</li>
<li>twitching</li>
<li>unusual bleeding or bruising</li>
<li>unusual excitement, nervousness, or restlessness</li>
<li>unusually pale skin</li>
<li>upper right abdominal or stomach pain</li>
<li>weight gain</li>
<li>yellow eyes and skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of milnacipran may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Feeling of warmth</li>
<li>headache, severe and throbbing</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>sudden sweating</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>change or problem with discharge of semen</li>
<li>decreased appetite</li>
<li>decreased interest in sexual intercourse</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>not able to ejaculate semen</li>
<li>rash</li>
<li>swelling of the testes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>bloated</li>
<li>change in taste</li>
<li>excess air or gas in the stomach or intestines</li>
<li>full feeling</li>
<li>heartburn</li>
<li>indigestion</li>
<li>irritability</li>
<li>loss of taste</li>
<li>night sweats</li>
<li>passing gas</li>
<li>sleepiness or unusual drowsiness</li>
<li>stomach discomfort or upset</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Swelling of the breasts or unusual milk production</li>
<li>unexpected or excess milk flow from the breasts</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to milnacipran: oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects were nausea, constipation, headache, dizziness, insomnia, and hot flush.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 39%), constipation (up to 16%)</p>
<p><b>Common</b> (1% to 10%): Vomiting, dry mouth, abdominal pain/upper abdominal pain, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension</p>
<p><b>Uncommon</b> (0.1% to 1%): Gastritis, stomatitis, hemorrhoids</p>
<p><b>Postmarketing reports</b>: Acute pancreatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 19%), dizziness (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Migraine, paresthesia, tremor, tension headache, hypoesthesia, dysesthesia, somnolence, dysgeusia, convulsions (including grand mal), loss of consciousness, Parkinsonism, memory impairment</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, vertigo</p>
<p><b>Rare</b> (0.01% to 0.1%): Balance disorder, cerebrovascular accident</p>
<p><b>Frequency not reported</b>: Serotonin syndrome<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hyperhidrosis (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Rash, pruritus, night sweats</p>
<p><b>Uncommon</b> (0.1% to 1%): Urticaria</p>
<p><b>Rare</b> (0.01% to 0.1%): Photosensitivity reaction</p>
<p><b>Postmarketing reports</b>: Erythema multiforme, Stevens Johnson syndrome, ecchymosis/cutaneous or mucosal bleeding<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flush (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Palpitations, hypertension, increased heart rate, increased blood pressure, tachycardia, chest pain, chest discomfort, flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, extrasystoles, hypotension, orthostatic hypotension, Raynaud's phenomena</p>
<p><b>Rare</b> (0.01% to 0.1%): Acute coronary syndrome, angina pectoris</p>
<p><b>Frequency not reported</b>: Contusion, peripheral edema</p>
<p><b>Postmarketing reports</b>: Supraventricular tachycardia, hypertensive crisis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Anxiety, depression, stress, irritability, agitation</p>
<p><b>Uncommon</b> (0.1% to 1%): Suicidal ideation, panic attack, confusion, hallucination, nightmares, decreased libido</p>
<p><b>Frequency not reported</b>: Physical dependence</p>
<p><b>Postmarketing reports</b>: Aggression, anger, delirium, homicidal ideation, elimination of psychomotor inhibition with suicidal risk, mood switch with episodes of mania, reactivation of delusions in patients with psychosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, decreased urine flow, cystitis, urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Pollakiuria, metrorrhagia</p>
<p><b>Rare</b> (0.01% to 0.1%): Amenorrhea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Chills, pyrexia, fatigue, fall, pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Tinnitus, feeling of body temperature change<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, fibromyalgia, muscle spasms, arthralgia, pain in extremity</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, dyspnea, sinusitis, nasopharyngitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p>
<p><b>Rare</b> (0.01% to 0.1%): Epistaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased or increased weight, hypercholesterolemia, decreased appetite</p>
<p><b>Postmarketing reports</b>: Hyponatremia, anorexia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry eye, mydriasis, reduced visual acuity</p>
<p><b>Postmarketing reports</b>: Accommodation disorder<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased hepatic enzymes</p>
<p><b>Rare</b> (0.01% to 0.1%): Hepatitis</p>
<p><b>Postmarketing reports</b>: Cytolytic hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Cystitis</p>
<p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Leukopenia, neutropenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Hyperprolactinemia, galactorrhea<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Savella (milnacipran)." Forest Pharmaceuticals, St. Louis, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Savella (milnacipran)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>327 Reviews</li>
<li>Drug class: serotonin-norepinephrine reuptake inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Savella &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Fibromyalgia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to milnacipran: oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects were nausea, constipation, headache, dizziness, insomnia, and hot flush.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 39%), constipation (up to 16%)</p><p><b>Common</b> (1% to 10%): Vomiting, dry mouth, abdominal pain/upper abdominal pain, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension</p><p><b>Uncommon</b> (0.1% to 1%): Gastritis, stomatitis, hemorrhoids</p><p><b>Postmarketing reports</b>: Acute pancreatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 19%), dizziness (up to 11%)</p><p><b>Common</b> (1% to 10%): Migraine, paresthesia, tremor, tension headache, hypoesthesia, dysesthesia, somnolence, dysgeusia, convulsions (including grand mal), loss of consciousness, Parkinsonism, memory impairment</p><p><b>Uncommon</b> (0.1% to 1%): Syncope, vertigo</p><p><b>Rare</b> (0.01% to 0.1%): Balance disorder, cerebrovascular accident</p><p><b>Frequency not reported</b>: Serotonin syndrome<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hyperhidrosis (up to 14%)</p><p><b>Common</b> (1% to 10%): Rash, pruritus, night sweats</p><p><b>Uncommon</b> (0.1% to 1%): Urticaria</p><p><b>Rare</b> (0.01% to 0.1%): Photosensitivity reaction</p><p><b>Postmarketing reports</b>: Erythema multiforme, Stevens Johnson syndrome, ecchymosis/cutaneous or mucosal bleeding<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flush (up to 12%)</p><p><b>Common</b> (1% to 10%): Palpitations, hypertension, increased heart rate, increased blood pressure, tachycardia, chest pain, chest discomfort, flushing</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, extrasystoles, hypotension, orthostatic hypotension, Raynaud's phenomena</p><p><b>Rare</b> (0.01% to 0.1%): Acute coronary syndrome, angina pectoris</p><p><b>Frequency not reported</b>: Contusion, peripheral edema</p><p><b>Postmarketing reports</b>: Supraventricular tachycardia, hypertensive crisis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 12%)</p><p><b>Common</b> (1% to 10%): Anxiety, depression, stress, irritability, agitation</p><p><b>Uncommon</b> (0.1% to 1%): Suicidal ideation, panic attack, confusion, hallucination, nightmares, decreased libido</p><p><b>Frequency not reported</b>: Physical dependence</p><p><b>Postmarketing reports</b>: Aggression, anger, delirium, homicidal ideation, elimination of psychomotor inhibition with suicidal risk, mood switch with episodes of mania, reactivation of delusions in patients with psychosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, decreased urine flow, cystitis, urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Pollakiuria, metrorrhagia</p><p><b>Rare</b> (0.01% to 0.1%): Amenorrhea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Chills, pyrexia, fatigue, fall, pain</p><p><b>Uncommon</b> (0.1% to 1%): Tinnitus, feeling of body temperature change<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, fibromyalgia, muscle spasms, arthralgia, pain in extremity</p><p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, dyspnea, sinusitis, nasopharyngitis</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Rare</b> (0.01% to 0.1%): Epistaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased or increased weight, hypercholesterolemia, decreased appetite</p><p><b>Postmarketing reports</b>: Hyponatremia, anorexia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p><p><b>Uncommon</b> (0.1% to 1%): Dry eye, mydriasis, reduced visual acuity</p><p><b>Postmarketing reports</b>: Accommodation disorder<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased hepatic enzymes</p><p><b>Rare</b> (0.01% to 0.1%): Hepatitis</p><p><b>Postmarketing reports</b>: Cytolytic hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Cystitis</p><p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Leukopenia, neutropenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Hyperprolactinemia, galactorrhea<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Savella (milnacipran)." Forest Pharmaceuticals, St. Louis, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Savella (milnacipran)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>327 Reviews</li>
<li>Drug class: serotonin-norepinephrine reuptake inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Savella &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Fibromyalgia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>